Jonathan Sadeh, MD, MSc: Afimetoran Improves Disease Activit

Results provide the first clinical evidence to suggest that afimetoran may offer a benefit to patients with cutaneous lupus erythematosus.

Related Keywords

, Jonathan Sadeh , Bristol Myers Squibb , American College Of Rheumatology , Global Program Leaders , Severity Index Activity , American College ,